Jeffrey A Hall1, Mark Rusten2, Raed D Abughazaleh3, Beverly Wuertz3, Vannesa Souksavong4, Paul Escher4, Frank Ondrey3. 1. Ohio Health Group, Columbus, Ohio, USA. 2. SoutheastHEALTH, Cape Girardeau, Missouri, USA. 3. Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, USA. 4. University of Minnesota Medical School, University of Minnesota, Minneapolis, Minnesota, USA.
Abstract
BACKGROUND: Peroxisome proliferator-activated receptor-gamma (PPAR-γ) activators have anti-cancer effects. Our objective was to determine the effect of PPAR-γ ligands 15-deoxy-D12,14 -Prostaglandin J2 (15-PGJ2 ) and ciglitazone on proliferation, apoptosis, and NF-κB in human oral squamous cell carcinoma cell lines. METHODS: NA and CA9-22 cells were treated in vitro with 15-PGJ2 and ciglitazone. Proliferation was measured by MTT colorimetric assay and cell cycle analysis performed via flow cytometry, apoptosis by caspase-3 colorimetric assay and poly-(ADP-ribose) polymerase cleavage on Western blot, and NF-κB activation by luciferase assays. RESULTS: MTT assays demonstrated dose-dependent decreases after 15-PGJ2 treatment in both cell lines, and S-phase cell cycle arrest was also demonstrated. NF-κB luciferase reporter gene activity decreased seven- and eightfold in NA and CA9-22 cells, respectively. Caspase-3 activity increased two- and eightfold in NA and CA9-22 cells, respectively. CONCLUSIONS: Our results suggest these agents, in addition to activating PPAR-γ, can downregulate NF-κB and potentiate apoptosis in oral cancer cells.
BACKGROUND:Peroxisome proliferator-activated receptor-gamma (PPAR-γ) activators have anti-cancer effects. Our objective was to determine the effect of PPAR-γ ligands 15-deoxy-D12,14 -Prostaglandin J2 (15-PGJ2 ) and ciglitazone on proliferation, apoptosis, and NF-κB in humanoral squamous cell carcinoma cell lines. METHODS: NA and CA9-22 cells were treated in vitro with 15-PGJ2 and ciglitazone. Proliferation was measured by MTT colorimetric assay and cell cycle analysis performed via flow cytometry, apoptosis by caspase-3 colorimetric assay and poly-(ADP-ribose) polymerase cleavage on Western blot, and NF-κB activation by luciferase assays. RESULTS:MTT assays demonstrated dose-dependent decreases after 15-PGJ2 treatment in both cell lines, and S-phase cell cycle arrest was also demonstrated. NF-κB luciferase reporter gene activity decreased seven- and eightfold in NA and CA9-22 cells, respectively. Caspase-3 activity increased two- and eightfold in NA and CA9-22 cells, respectively. CONCLUSIONS: Our results suggest these agents, in addition to activating PPAR-γ, can downregulate NF-κB and potentiate apoptosis in oral cancer cells.
Authors: Donna E Seabloom; Arthur R Galbraith; Anna M Haynes; Jennifer D Antonides; Beverly R Wuertz; Wendy A Miller; Kimberly A Miller; Vernon E Steele; Chen S Suen; M Gerard O'Sullivan; Frank G Ondrey Journal: Cancer Prev Res (Phila) Date: 2016-12-19
Authors: Robert L Keith; Patrick J Blatchford; Daniel T Merrick; Paul A Bunn; Brandi Bagwell; Lori D Dwyer-Nield; Mary K Jackson; Mark W Geraci; York E Miller Journal: Cancer Prev Res (Phila) Date: 2019-07-15
Authors: Y Tsubouchi; H Sano; Y Kawahito; S Mukai; R Yamada; M Kohno; K Inoue; T Hla; M Kondo Journal: Biochem Biophys Res Commun Date: 2000-04-13 Impact factor: 3.575
Authors: Christopher M Lyon; Donna M Klinge; Kieu C Do; Marcie J Grimes; Cindy L Thomas; Leah A Damiani; Thomas H March; Christine A Stidley; Steven A Belinsky Journal: Carcinogenesis Date: 2009-12 Impact factor: 4.944